Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 5
2005 6
2006 4
2007 5
2008 8
2009 4
2010 5
2011 4
2012 6
2013 10
2014 15
2015 12
2016 11
2017 13
2018 13
2019 31
2020 22
2021 28
2022 23
2023 15
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

230 results

Results by year

Filters applied: . Clear all
Page 1
USP22 regulates lipidome accumulation by stabilizing PPARγ in hepatocellular carcinoma.
Ning Z, Guo X, Liu X, Lu C, Wang A, Wang X, Wang W, Chen H, Qin W, Liu X, Zhou L, Ma C, Du J, Lin Z, Luo H, Otkur W, Qi H, Chen D, Xia T, Liu J, Tan G, Xu G, Piao HL. Ning Z, et al. Among authors: liu j. Nat Commun. 2022 Apr 21;13(1):2187. doi: 10.1038/s41467-022-29846-9. Nat Commun. 2022. PMID: 35449157 Free PMC article.
Furmonertinib (AST2818) versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer (FURLONG): a multicentre, double-blind, randomised phase 3 study.
Shi Y, Chen G, Wang X, Liu Y, Wu L, Hao Y, Liu C, Zhu S, Zhang X, Li Y, Liu J, Cao L, Cheng Y, Zhao H, Zhang S, Zang A, Cui J, Feng J, Yang N, Liu F, Jiang Y, Gu C; FURLONG investigators. Shi Y, et al. Among authors: liu j. Lancet Respir Med. 2022 Nov;10(11):1019-1028. doi: 10.1016/S2213-2600(22)00168-0. Epub 2022 Jun 2. Lancet Respir Med. 2022. PMID: 35662408 Clinical Trial.
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial.
Cheng AL, Kang YK, Chen Z, Tsao CJ, Qin S, Kim JS, Luo R, Feng J, Ye S, Yang TS, Xu J, Sun Y, Liang H, Liu J, Wang J, Tak WY, Pan H, Burock K, Zou J, Voliotis D, Guan Z. Cheng AL, et al. Among authors: liu j. Lancet Oncol. 2009 Jan;10(1):25-34. doi: 10.1016/S1470-2045(08)70285-7. Epub 2008 Dec 16. Lancet Oncol. 2009. PMID: 19095497 Clinical Trial.
Working Together to Advance Cardio-Oncology in China.
Xia Y, Liu J. Xia Y, et al. Among authors: liu j. JACC CardioOncol. 2020 Mar 17;2(1):144-145. doi: 10.1016/j.jaccao.2020.02.008. eCollection 2020 Mar. JACC CardioOncol. 2020. PMID: 34396222 Free PMC article. No abstract available.
Membrane remodelling in bacteria.
Bohuszewicz O, Liu J, Low HH. Bohuszewicz O, et al. Among authors: liu j. J Struct Biol. 2016 Oct;196(1):3-14. doi: 10.1016/j.jsb.2016.05.010. Epub 2016 Jun 2. J Struct Biol. 2016. PMID: 27265614 Free PMC article. Review.
Interim survival analysis of the randomized phase III GEMSTONE-302 trial: sugemalimab or placebo plus chemotherapy as first-line treatment for metastatic NSCLC.
Zhou C, Wang Z, Sun M, Cao L, Ma Z, Wu R, Yu Y, Yao W, Sun S, Chen J, Zhuang W, Cui J, Chen X, Lu Y, Shen H, Hu C, Liu J, Liu Y, Wang M, Li X, Sun P, Shu Y, Zhou J, Li J, Gu K, Wang C, Zhao H, Zhang Y, Liu C, Wang J, Chen R, Qin M, Wang H, Yang J. Zhou C, et al. Among authors: liu j. Nat Cancer. 2023 Jun;4(6):860-871. doi: 10.1038/s43018-023-00578-z. Epub 2023 Jun 15. Nat Cancer. 2023. PMID: 37322367 Clinical Trial.
EZH2-CCF-cGAS Axis Promotes Breast Cancer Metastasis.
Duan D, Shang M, Han Y, Liu J, Liu J, Kong SH, Hou J, Huang B, Lu J, Zhang Y. Duan D, et al. Among authors: liu j. Int J Mol Sci. 2022 Feb 4;23(3):1788. doi: 10.3390/ijms23031788. Int J Mol Sci. 2022. PMID: 35163710 Free PMC article.
Research progress of residual stress measurement methods.
Li X, Liu J, Wu H, Miao K, Wu H, Li R, Liu C, Fang W, Fan G. Li X, et al. Among authors: liu j. Heliyon. 2024 Mar 26;10(7):e28348. doi: 10.1016/j.heliyon.2024.e28348. eCollection 2024 Apr 15. Heliyon. 2024. PMID: 38586409 Free PMC article. Review.
Poly[μ₇-sulfanediyldiacetato-disilver(I)].
Hao XM, Chen G, Gu CS, Liu JW. Hao XM, et al. Acta Crystallogr C. 2013 Aug;69(Pt 8):826-8. doi: 10.1107/S0108270113017319. Epub 2013 Jul 13. Acta Crystallogr C. 2013. PMID: 23907868
230 results